| Devatis AG - Apremilast Devatis 30 mg, Filmtabletten | | 70016 | | 02 | | Apremilast Devatis 30 mg | | Filmtabletten | | L04AA32 | | Apremilast | | 22.07.2025 | | |
| | Composition | | apremilastum 30 mg, cellulosum microcristallinum, lactosum monohydricum 180 mg, carmellosum natricum conexum corresp. natrium 0.81 mg, magnesii stearas, Überzug: hypromellosum, titanii dioxidum, macrogolum 400, E 172 (flavum), E 172 (rubrum), talcum, E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | Active Agent | Dose |
|---|
| Apremilastum | 30 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Nigrum) | | | | (Rubrum) | | | | Carmellosum Natricum Conexum | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hypromellosum | | Überzug | | Lactose Monohydrate | 180 mg | | | Macrogol | 400 | | | Magnesii Stearas | | | | Pro Compresso Obducto | | | | Talcum | | | | Titanium Dioxide | | |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 56 | PR | PR | B | | Yes |
|
|
